EDGAR Filing Documents for 0001104659-21-134482

Form F-3 - Registration statement by foreign private issuers:

SEC Accession No. 0001104659-21-134482

Filing Date

2021-11-04

Accepted

2021-11-04 17:02:02

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	F-3	tm2131851-3_f3.htm	F-3	517810
2	EXHIBIT 5.1	tm2131851d4_ex5-1.htm	EX-5.1	34745
3	EXHIBIT 23.1	tm2131851d4_ex23-1.htm	EX-23.1	2270
4	GRAPHIC	lg_proqr-4c.jpg	GRAPHIC	33788
	Complete submission text file	0001104659-21-134482.txt		602490

Mailing Address ZERNIKEDREEF 9 LEIDEN P7 2333 CK

Business Address ZERNIKEDREEF 9 LEIDEN P7 2333 CK 31 88 166 7000

ProQR Therapeutics N.V. (Filer) CIK: 0001612940 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: F-3 | Act: 33 | File No.: 333-260780 | Film No.: 211380979
SIC: 2834 Pharmaceutical Preparations